|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 1674 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 1074 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 1174 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 1074 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 1074 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 1474 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 1074 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 974 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 974 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 674 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 574 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 874 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 774 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 674 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 574 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 474 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 974 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 957 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 757 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 757 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 857 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 1057 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 1057 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 957 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 1157 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 1157 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 857 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 1057 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 557 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 757 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 657 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 957 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 757 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 157 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 1057 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 857 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 957 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 1457 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Choroidal hemangioma 10 year old black malevaatamisi: 1010 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidaug 13, 2025
|
|
Choroidal hemangioma 10 year old black malevaatamisi: 1110 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidaug 13, 2025
|
|
Choroidal hemangioma 10 year old black malevaatamisi: 1010 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 770 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 570 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 670 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 870 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 470 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Choroidal Nevus with Halovaatamisi: 12aug 13, 2025
|
|
Choroidal Nevus with Halovaatamisi: 7aug 13, 2025
|
|
Choroidal Nevus with Halovaatamisi: 12aug 13, 2025
|
|
Choroidal Nevus with Halovaatamisi: 9aug 13, 2025
|
|
CRAO and NVI (rubeosis)vaatamisi: 4aug 13, 2025
|
|
CRAO and NVI (rubeosis)vaatamisi: 14aug 13, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 1523-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 1323-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 1623-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 1323-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 723-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 1623-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 723-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 823-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 1123-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 1023-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 823-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 923-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 1423-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1548 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1548 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1148 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1048 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1448 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1248 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1548 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1448 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1248 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 948 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1348 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 1648 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1128 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1228 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1228 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1428 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1228 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1228 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1228 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1328 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1028 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1128 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1828 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1228 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 928 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 828 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1128 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1328 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1328 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 828 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1328 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 1928 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 1267 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 1167 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 1267 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
|
|
